Nicotinamide mononucleotide aging refers to biological effects of nicotinamide mononucleotide on aging-related metabolic decline. Nicotinamide mononucleotide is a direct NAD precursor involved in intracellular NAD biosynthesis. With aging, reduced NAD availability limits cellular energy production and repair capacity. Nicotinamide mononucleotide aging research explores restoration of metabolic efficiency, mitochondrial performance, and cellular homeostasis. By replenishing NAD pools, this approach may support tissue function and stress resilience. Nicotinamide mononucleotide aging represents a targeted strategy within metabolic longevity research aimed at addressing age-related energy failure and functional decline.
Title : Change your genes – Change your life: Epigenetics of longevity
Kenneth R Pelletier, University of California School of Medicine, United States
Title : Improving mobility and health in over 45,000 humans using nanomedicine
Thomas J Webster, Brown University, United States
Title : An introduction to alchemical facial acupuncture: Sparking the shen
Mary Elizabeth Wakefield, Chi-Akra Center for Ageless Aging, United States
Title : Decoding the secret of longevity through big data: Noncoding RNAs—not proteins—drive animal lifespan evolution
Anyou Wang, DIFIBER LLC, United States
Title : Aspirin guided by coronary artery calcium scoring for primary prevention in persons with subclinical coronary heart disease
Arthur J Siegel, McLean Hospital, United States
Title : When BMI misleads: Integrating body composition, biomarkers, and personalized interventions for cardiometabolic healthspan in aging Asian and European cohorts
Narendra Kumar, HeartbeatsZ Academy, United Kingdom